Phase II Weekly Vinblastine for Chemotherapy-Naive Children With Progressive Low-Grade Glioma: A Canadian Pediatric Brain Tumor Consortium Study [Pediatric Oncology]
Conclusion
Vinblastine administered once per week is well tolerated in children with treatment naïve PLGG. Overall survival and PFS are comparable to current therapies, with a favorable toxicity profile and a maintained quality of life.
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Lassaletta, Scheinemann, Zelcer, Hukin, Wilson, Jabado, Carret, Lafay-Cousin, Larouche, Hawkins, Pond, Poskitt, Keene, Johnston, Eisenstat, Krishnatry, Mistry, Arnoldo, Ramaswamy, Huang, Bartels, Tabori, Bouffet Tags: Brain Tumors, Chemotherapy, CNS Tumors Pediatric Oncology Source Type: research
More News: Astrocytoma | Brain | Brain Cancers | Brain Tumor | Cancer & Oncology | Chemotherapy | Children | Glioma | Neurofibromatosis | Neurology | Pediatrics | Pilocytic Astrocytoma | Study | Toxicology